David J. Wambeke

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Minneapolis, MN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Emily Johns, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David J. Wambeke

Form 4 holding Chief Business Officer

DiaMedica Therapeutics Inc.

Security class
Voting Common Shares, no par value per share
Shares / value
527,114
Estimated value
$1,475,919
Report date
01 Jun 2024
Price
$2.80
Ownership
Direct

Insider Reports Filed by David J. Wambeke

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .